CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-23 | Costa Carlos Chief People Officer | Sale 10b5-1 | −857 | $10.17 | $9K | 0 |
| 2024-09-20 | Costa Carlos Chief People Officer | Sale 10b5-1 | −35,756 | $10.04 | $359K | 0 |
| 2024-09-18 | Costa Carlos Chief People Officer | Sale 10b5-1 | −11,574 | $10.05 | $116K | 0 |
| 2024-09-17 | Costa Carlos Chief People Officer | Sale 10b5-1 | −10,272 | $10.04 | $103K | 0 |
| 2024-09-16 | Costa Carlos Chief People Officer | Sale 10b5-1 | −400 | $10.00 | $4K | 0 |
| 2024-09-09 | Bellon Steven F. Chief Scientific Officer | Sale 10b5-1 | −20,000 | $9.50 | $190K | 101,957 |
| 2024-03-11 | Cavalie Fanny Chief Strategy/Bus Ops Officer | Sale | −11,000 | $6.56 | $72K | 75,992 |
| 2023-08-16 | Agresta Samuel Chief Medical Officer | Sale | −311,297 | $8.25 | $2.6M | 0 |
Page 1 of 1 · 8 trades